Stock Insiders: Dragonfly Biosciences inches closer to ASX listing as a global cannabidiol retailer

Stock Insiders is a new podcast series focussed on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm. 

In this episode Oriel chats to Regan Saveall the CEO of Dragonfly Biosciences.

Dragonfly Biosciences is the proprietor of the “Dragonfly CBD” brand and is a premium retailer of cannabidiol in the UK, supplying CBD products to national retail chains and international markets.

The company aims to expand its business and product range in line with legislative changes in Europe, the US and Australia.

Dragonfly made headlines in December with its announcement of an ASX listing as it expands into the Asia-Pacific region.

To hear more about the company’s leadership, misconceptions around medicinal cannabis oil, international plans and ASX listing, click below.

You might be interested in

Be the first to comment

Leave a Reply

Your email address will not be published.


*